<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04687865</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL20_0964</org_study_id>
    <nct_id>NCT04687865</nct_id>
  </id_info>
  <brief_title>Constitution of a Biobank for Studies Related to Organ Transplantation (Lyon Centaure Biocollection)</brief_title>
  <official_title>Biological Material Bank for Studies Related to Organ Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to constitute a collection of biological materials from in transplant&#xD;
      patients and to provide biological materials from transplanted patients in order :&#xD;
&#xD;
      i) validate new theory on the cause of allograft loss, ii) develop innovative biomarker for&#xD;
      rejection and other transplantation-related conditions (such as BK virus nephropathy,&#xD;
      Post-transplant lymphoproliferative disorder ( PTLD) ...)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2020</start_date>
  <completion_date type="Anticipated">January 8, 2040</completion_date>
  <primary_completion_date type="Anticipated">January 8, 2040</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the biological samples</measure>
    <time_frame>At inclusion</time_frame>
    <description>The goal of this study is to provide biological materials from transplanted patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change Biological Samples</measure>
    <time_frame>Month 1</time_frame>
    <description>The goal of this study is to provide biological materials from transplanted patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change Biological Samples</measure>
    <time_frame>Month 3</time_frame>
    <description>The goal of this study is to provide biological materials from transplanted patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change Biological Samples</measure>
    <time_frame>Month 6</time_frame>
    <description>The goal of this study is to provide biological materials from transplanted patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change Biological Samples</measure>
    <time_frame>Month 12</time_frame>
    <description>The goal of this study is to provide biological materials from transplanted patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change Biological Samples</measure>
    <time_frame>Month 60</time_frame>
    <description>The goal of this study is to provide biological materials from transplanted patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change Biological Samples</measure>
    <time_frame>Month 120</time_frame>
    <description>The goal of this study is to provide biological materials from transplanted patients</description>
  </primary_outcome>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Organ Transplantation</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biobank</intervention_name>
    <description>For each patient included in the study the following samples will be collected at the indicated time points after transplantation:&#xD;
Serum samples and plasma sample: Day1, Month 1, Month 3, Month 6, Month 12, month 60, month 120 and at the time of each allograft biopsy.&#xD;
Urines samples: Month 3 and Month 12 and at the time of each allograft biopsy.&#xD;
Peripheral Blood Mononuclear Cell (PBMC): for each organ allograft biopsy.&#xD;
Allograft biopsies: systematically at Month 3, and Month 12, and for cause in case of allograft dysfunction.</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample for DNA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All adult patients that received a solid organ transplant at the transplantation department&#xD;
        of Lyon University Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or Female patient ≥18 years old&#xD;
&#xD;
          -  Recipient of an organ transplant&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-affiliation to a social security system.&#xD;
&#xD;
          -  Subjects deprived of liberties&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Olivier Thaunat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Edouard Herriot Hospital - Transplantation department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivier Thaunat, MD</last_name>
    <phone>04 72 11 69 28</phone>
    <phone_ext>+33</phone_ext>
    <email>olivier.thaunat@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emmanuel Morelon, MD</last_name>
    <phone>04 72 11 01 70</phone>
    <phone_ext>+33</phone_ext>
    <email>emmanuel.morelon@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <state>Rhône</state>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier THAUNAT, MD</last_name>
      <phone>04.72.11.69.28</phone>
      <phone_ext>+33</phone_ext>
      <email>olivier.thaunat@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>DANIEL SPERANDO, CRA</last_name>
      <phone>04.72.11.69.28</phone>
      <phone_ext>+33</phone_ext>
      <email>daniel.sperando@chu-lyon.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 16, 2020</study_first_submitted>
  <study_first_submitted_qc>December 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2020</study_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

